Netskope heads into the week carrying a sharp internal contradiction — short interest has roughly doubled over the past month while the analyst community remains uniformly constructive, a standoff that sets up the next earnings print as the deciding test.
The short-side story is the most striking feature of the current setup. Estimated short interest has more than doubled over the past 30 days, climbing to roughly 28.7 million shares — the highest level in the 30-day history of this data. On the single session of July 23, shorts added over 23% in one day, a jolt that brings the week's net change to just 1.5% but underscores how volatile the positioning has been. The ORTEX short score reflects that pressure, running at 71.9 — a level that has barely moved below 67 over the past two weeks. Because float data is unavailable, a clean percent-of-float figure cannot be confirmed, but the raw trajectory is unambiguous: borrowed share count has moved from ~14 million in mid-June to nearly 29 million now, a structural shift in how the market is leaning.
The lending market, however, does not yet look squeezed. Availability has tightened this week — from above 150% a few days ago to around 84% today — but that still leaves a reasonably healthy supply of shares to borrow relative to current short interest. Cost to borrow is rising, up 20% on the week to 0.76%, yet in absolute terms it remains low. There is no meaningful squeeze pressure here: shorts can still add positions without paying a premium, and the borrow infrastructure remains far from strained. Options positioning tells a similar story — the put/call ratio has actually eased on the latest session to 0.47, pulling back from a cluster of 0.51 readings that coincided with the stock's worst week, and the z-score of 0.54 places current positioning close to its 20-day average. Neither the lending market nor options are flagging imminent stress for short sellers.
The Street remains firmly in the bull camp, and that's what makes the divergence interesting. Every analyst in the recent changes list maintained their positive rating through the June selloff — Morgan Stanley, Wells Fargo, Mizuho, TD Cowen, Piper Sandler, RBC, and BMO all held Overweight or Outperform calls even as they trimmed targets after the June 3 earnings miss. Keybanc went the other direction on July 16, raising its target from $14 to $16 while keeping an Overweight — a notable move given it came after targets had been cut across the board. The consensus mean target is $16.11, implying roughly 40% upside to the current $11.53 close. The bull case centres on SASE market growth and cloud-AI security demand; the bear case is more immediate — net new ARR disappointed last quarter, net retention rates slipped, and the business needs to demonstrate that a scaling sales force can convert pipeline into durable growth. On factor scores, forward EPS growth expectations rank in the 85th percentile, but near-term EPS momentum ranks in the bottom single digits, an uncomfortable split between narrative and current execution.
The insider register adds one more layer. ICONIQ Strategic Partners — already the largest institutional holder at 16.6% of shares — spent roughly $11 million buying stock in the July 8–13 window across three separate transactions, accumulating at prices between $11.67 and $12.42. That buying came against a backdrop of CEO Sanjay Beri selling $6.1 million worth of stock on July 1, though that sale coincided with a large equity award, making the net picture less bearish than the headline number implies. ICONIQ's willingness to add aggressively at current levels, given it can see the company's private metrics, is the most concrete signal of insider conviction available right now.
The peer group offers little comfort on the week. CRWD fell nearly 10% over the past seven days, RBRK dropped 7.3%, and ZS shed 5%. NTSK's own 15% decline was steeper than most of its closest comparables, suggesting the stock carried idiosyncratic selling pressure beyond the sector's general weakness. With earnings scheduled for September 2, the next six weeks will determine whether the short-interest build was anticipating a repeat of the June miss or was simply momentum-chasing a falling price — and whether ICONIQ's open-market buying at $11–$12 proves well-timed.
See the live data behind this article on ORTEX.
Open NTSK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
